CCA
BIO icon

Checchi Capital Advisers’s Bio-Rad Laboratories Class A BIO Stock Holding History

Checchi Capital Advisers’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-334
Closed -$48K – 485
2016
Q2 		$48K Buy
334
+201
+151% +$28.7K 0.01% 861
2016
Q1 		$18K Buy
+133
New +$17.5K ﹤0.01% 1158

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Checchi Capital Advisers's BIO Position: Q3 2016 in Review

Checchi Capital Advisers sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2016, closing a stake of 334 shares — an estimated $48K sold.

Checchi Capital Advisers first reported a position in BIO in Q1 2016 and held it in 2 quarters. The position peaked at $48K in Q2 2016. 241 funds tracked by Wall St. Rank hold BIO as of Q3 2016.

  • Checchi Capital Advisers reported no remaining Bio-Rad Laboratories Class A position as of Q3 2016 after selling out during the quarter.
  • Checchi Capital Advisers sold 334 Bio-Rad Laboratories Class A shares in Q3 2016, an estimated $48K.
  • Checchi Capital Advisers first reported a position in Bio-Rad Laboratories Class A in Q1 2016 and held it in 2 quarters.
  • Checchi Capital Advisers's Bio-Rad Laboratories Class A position peaked at $48K in Q2 2016.
  • 241 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2016.

Based on Checchi Capital Advisers's 13F filing for Q3 2016, filed 10 Nov 2016.